708 related articles for article (PubMed ID: 16830359)
1. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.
Martin GR; Beck PL; Sigalet DL
World J Gastroenterol; 2006 Jul; 12(26):4117-29. PubMed ID: 16830359
[TBL] [Abstract][Full Text] [Related]
2. Short bowel syndrome: the role of GLP-2 on improving outcome.
Wallis K; Walters JR; Gabe S
Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):526-32. PubMed ID: 19474717
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
Sigalet DL; Bawazir O; Martin GR; Wallace LE; Zaharko G; Miller A; Zubaidi A
Dig Dis Sci; 2006 Sep; 51(9):1557-66. PubMed ID: 16927140
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
Vegge A; Thymann T; Lund P; Stoll B; Bering SB; Hartmann B; Jelsing J; Qvist N; Burrin DG; Jeppesen PB; Holst JJ; Sangild PT
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G277-85. PubMed ID: 23764891
[TBL] [Abstract][Full Text] [Related]
5. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.
Lai SW; de Heuvel E; Wallace LE; Hartmann B; Holst JJ; Brindle ME; Chelikani PK; Sigalet DL
PLoS One; 2017; 12(7):e0181453. PubMed ID: 28738080
[TBL] [Abstract][Full Text] [Related]
6. Short bowel syndrome in children: current and potential therapies.
Uko V; Radhakrishnan K; Alkhouri N
Paediatr Drugs; 2012 Jun; 14(3):179-88. PubMed ID: 22452596
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
[TBL] [Abstract][Full Text] [Related]
8. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
Martin GR; Wallace LE; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
Thymann T; Stoll B; Mecklenburg L; Burrin DG; Vegge A; Qvist N; Eriksen T; Jeppesen PB; Sangild PT
J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
[TBL] [Abstract][Full Text] [Related]
11. Exogenous glucagon-like peptide-2 improves outcomes of intestinal adaptation in a distal-intestinal resection neonatal piglet model of short bowel syndrome.
Suri M; Turner JM; Sigalet DL; Wizzard PR; Nation PN; Ball RO; Pencharz PB; Brubaker PL; Wales PW
Pediatr Res; 2014 Oct; 76(4):370-7. PubMed ID: 24995913
[TBL] [Abstract][Full Text] [Related]
12. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.
Martin GR; Wallace LE; Hartmann B; Holst JJ; Demchyshyn L; Toney K; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G431-8. PubMed ID: 15388486
[TBL] [Abstract][Full Text] [Related]
13. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like Peptide-2.
Estall JL; Drucker DJ
Annu Rev Nutr; 2006; 26():391-411. PubMed ID: 16602931
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome.
Liu X; Nelson DW; Holst JJ; Ney DM
Am J Clin Nutr; 2006 Nov; 84(5):1142-50. PubMed ID: 17093168
[TBL] [Abstract][Full Text] [Related]
17. Gut hormones in the treatment of short-bowel syndrome and intestinal failure.
Jeppesen PB
Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):14-20. PubMed ID: 25485516
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.
Jeppesen PB; Hartmann B; Thulesen J; Graff J; Lohmann J; Hansen BS; Tofteng F; Poulsen SS; Madsen JL; Holst JJ; Mortensen PB
Gastroenterology; 2001 Mar; 120(4):806-15. PubMed ID: 11231933
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
Jeppesen PB
JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
[TBL] [Abstract][Full Text] [Related]
20. Differential Effects on Intestinal Adaptation Following Exogenous Glucagon-Like Peptide 2 Therapy With and Without Enteral Nutrition in Neonatal Short Bowel Syndrome [Formula: see text].
Lim DW; Diané A; Muto M; Vine DF; Nation PN; Wizzard PR; Sigalet DL; Bigam DL; Pencharz PB; Turner JM; Wales PW
JPEN J Parenter Enteral Nutr; 2017 Feb; 41(2):156-170. PubMed ID: 27660290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]